August 2018 Volume 14, Issue 8

Volume 14, Issue 8 | August 2018

August 2018

In this Issue

Diagnostics

Drug Discovery News Placeholder Image

Can microRNA solve a big AD problem?

Researchers at Indiana University think they might be on to a simple, early test for Alzheimer's disease
Drug Discovery News Placeholder Image

AI imaging

Progenics shares data supporting imaging analysis technology in prostate cancer
Drug Discovery News Placeholder Image

Precision medicine and pancreatic cancer

Evidence shows patients benefit from molecular profiling
Drug Discovery News Placeholder Image

New tools for Alzheimer’s

Coalition of philanthropists commit more than $30 million for better ways to diagnose Alzheimer's disease

Discovery

Drug Discovery News Placeholder Image

Testing therapeutic potential

TSRI chemists design ‘miniecosystems’ to test drug function
Drug Discovery News Placeholder Image

Teaming up to understand single-molecule science

Trio of partners seek a deeper understanding of biology and early-stage drug development
Drug Discovery News Placeholder Image

Agenus discovery enhances activity of cancer-fighting antibodies

Findings published in Cancer Cell; company’s next-generation anti-CTLA-4 antibody slated for IND in 2018
Drug Discovery News Placeholder Image

Sonnet completes discovery phase of immuno-oncology program

Along with this comes the initiation of CMC development of platform assets
Drug Discovery News Placeholder Image

AMSBIO launches new screening company

Joint venture with University of Strathclyde looks toward developing a new kind of microfluidics platform

Research & Development

Drug Discovery News Placeholder Image

Shedding some light on the 5-8-5 scaffold

A new approach from FSU could help researchers unlock a promising but hard to synthesize molecular structure
Drug Discovery News Placeholder Image

A new bladder cancer biomarker

Mount Sinai researchers use data science and genomics to help determine best treatment options
Drug Discovery News Placeholder Image

Methyldopa mechanism

Small-molecule approach blocks autoimmunity in type 1 diabetes
Drug Discovery News Placeholder Image

An antibiotic fix with F6?

Purdue researchers identify antibacterial compound that is less prone to antibiotic resistance
Drug Discovery News Placeholder Image

Evonetix gains £1.3M for gene synthesis project

Innovate UK funding will support development of a novel enzymatic process for DNA synthesis

Clinical Trials

Drug Discovery News Placeholder Image

Looking for order in chaos

Data integration key to faster clinical trials
Drug Discovery News Placeholder Image

Good to go with INDIGO-1

Gemphire reports notable reductions in triglyceride levels in Phase 2b trial of gemcabene
Drug Discovery News Placeholder Image

‘PROMISE’-ing results against migraine

Data demonstrate eptinezumab efficacy further improved at one year after third and fourth quarterly infusions
Drug Discovery News Placeholder Image

‘ADAPT’ or fail?

Biotargeting system aims to drive clinical trial success in cancer studies
Drug Discovery News Placeholder Image

Positive Phase 2 Data for bardoxolone methyl in CKD

Significant improvement in kidney function maintained in Alport syndrome patients after 48 weeks

Special Reports

Drug Discovery News Placeholder Image

Special Report on Drug Delivery: Penetrating the impenetrable

Researchers are working hard to find novel and interesting ways to overcome problems of getting across the blood-brain barrier

Feature

Drug Discovery News Placeholder Image

Show Preview: Basel Life/EMBO

Lively times ahead at Basel Life, as the annual congress gets set to bridge the worlds of science and business, focusing on European life sciences

Editor's Focus

Drug Discovery News Placeholder Image

Editor’s Focus: Science isn’t always friendly, but it isn’t the enemy

Somewhere along the line, it became sort of "popular" to denigrate science and scientists, and it's time to turn that trend around

Commentary

Drug Discovery News Placeholder Image

Listening to the chemistry talk

Medicine is moving decade by decade to be more information-rich and constrained by the resulting increases in cost from advances in both the physics and the chemistry; the tools in the black bag of 1960 are not enough for today’s best result

Guest Commentary: How genomic testing is redefining cancer research

Improved genomic sequencing techniques are increasing the rigor of the clinical development process and genomic profiling is helping to identify new therapeutic targets as well as biomarkers of treatment response

Q&A

Drug Discovery News Placeholder Image

Q&A: GigaGen growth and the NIH

GigaGen CEO discusses how NIH programs and funding help early-stage companies such as GigaGen get up and running, providing support in clinical and commercial spheres

Preclinical

Drug Discovery News Placeholder Image

A model that mimics

New mouse model could illuminate autism subtype
Drug Discovery News Placeholder Image

Touring the oncology landscape

A roundup of recent preclinical cancer research
Drug Discovery News Placeholder Image

Parkinson’s potential

MANF protein proves capable of protecting dopaminergic neurons, staving off motor dysfunction
Drug Discovery News Placeholder Image

A loss for liver disease?

Conatus Pharmaceuticals’ pan-caspase inhibitor emricasan improves survival and portal hypertension in a mouse model of cirrhosis

Business & Government Policy

Drug Discovery News Placeholder Image

For your approval

A collection of recent regulatory approvals and other actions globally
Drug Discovery News Placeholder Image

On the cutting edge

A roundup of instrumentation, software and other tools and technology news
Drug Discovery News Placeholder Image

Attacking arthritis

University of Birmingham forms spinout to develop new therapeutic target for RA
Drug Discovery News Placeholder Image

Making progress

A roundup of recent pharma/biotech milestones

Contract Services

Drug Discovery News Placeholder Image

CDMO invests in ‘solid’ growth

JPS announces major investment and facility expansion, focused on oral solid dose manufacturing
Drug Discovery News Placeholder Image

A new mouse for Deerfield

Acquisition of Ablexis sets stage for market expansion with AlivaMab Mouse and founding of AlivaMab Discovery Services
Drug Discovery News Placeholder Image

Novacap completes acquisition of PCI

With the purchase, the company expands its pharmaceutical offerings in the U.S.
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Gold circles with attached purple corkscrew shapes represent gold nanoparticles against a black background.

Driving gene therapy with nonviral vectors 

Learn why nonviral vectors are on the rise in gene therapy development.
A 3D digital illustration of a viral spike protein on a cell surface, surrounded by colorful, floating antibodies in the background

Milestone: Leapfrogging to quantitative, high throughput protein detection and analysis

Researchers continuously push the boundaries of what’s possible with protein analysis tools.
Blue cancer cells attached to a cellular surface against a bright blue background in a 3D rendering of a cancer infection.

Advancing immuno-oncology research with cellular assays

Explore critical insights into immunogenicity and immunotoxicity assays for cancer therapies.
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue